Clinical Trial Update: Baroloop Multicenter Trial (Baroloop MCT) [NA]

View source ↗

Summary

The Baroloop Multicenter Trial (Baroloop MCT) by neuroloop GmbH is currently recruiting participants with hypertension resistant to conventional therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Baroloop

Snippet

Sponsor: neuroloop GmbH | Conditions: Hypertension, Resistant to Conventional Therapy | NA | Status: RECRUITING